[1] 赵宗江,仇琪,刘昆,等.三七总皂苷对阿霉素肾病大鼠肾组织转化生长因子1表达的影响[J].中国中西医结合肾病杂志,2008,9(3):240-242. [2] 杨晓晖,吕仁和,戴京璋,等.止消通脉宁对糖尿病微血管合并症患者心功能影响的临床研究[J].北京中医药大学学报,2001,24(5):45-47. [3] Xu J, Carretero O A, Lin C X, et al.Role of cardiac overexpression of ANG Ⅱ in the regulation of cardiac function and remodeling postmyocardial infarction[J].American Journal of Physiology-Heart and Circulatory Physiology,2007; 293:H1900-H1907. [4] Masuda T,Muto S,Fujisawa G,et al.Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy[J].American Journal of PhysiologyHeart and Circulatory Physiology. 2012,302(9):H1871-83. [5] 周敏,钟惠菊,吴晓英,等.培哚普利对糖尿病大鼠心肌病变及TGF-β1表达的影响[J].中国现代医学杂志,2009,19(21):3227-3231. [6] Fiordaliso F, Li B, Latini R, et al. Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II-dependent [J].LabInvest,2000,80:513-527. [7] 李敏,林兰,倪青,等.糖心平对实验性糖尿病心肌病变血管紧张素Ⅱ及其1型受体mRNA变化的影响[J].医学研究杂志,2007,36(4):31-34. [8] Kajstura J, Fiordaliso F, Andreoli A M, et al.IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensinⅡ-ediated oxidative stress[J].Diabetes,2001,50(6):1414-1424. [9] 张忠,杨艳宏,焦向英,等.血管紧张素抑制剂对糖尿病心脏损伤的保护机制[J].中国现代医生,2011,49(19):12-16. |